| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.510 | 16.667 | 17.600 | 18.211 | 13.360 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.510 | 16.668 | 17.601 | 18.211 | 13.368 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 9.214 | 11.863 | 11.912 | 13.908 | 14.446 | 4.443 | 67 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -6.705 | 4.804 | 5.689 | 4.303 | -1.078 | -4.443 | -67 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -6.705 | 4.637 | 5.513 | 4.121 | -1.212 | -4.443 | -67 | 0 | 0 | 0 |
| Employees | 1 | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lomaco Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 408 | 188 | 37 | 0 | 432 | 68 | 0 | 0 | 0 | 0 |
| Current Assets | 4.655 | 11.705 | 17.552 | 17.249 | 12.916 | 4.366 | 4.269 | 4.282 | 4.269 | 4.246 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.929 | 3.645 | 1.808 | 3.437 | 154 | 211 | 206 | 207 | 207 | 205 |
| Cash | -274 | 8.061 | 15.744 | 13.812 | 12.762 | 4.155 | 4.063 | 4.075 | 4.063 | 4.040 |
| Shareholders Funds | 3.483 | 8.085 | 10.767 | 14.690 | 9.021 | 4.407 | 4.243 | 4.256 | 4.243 | 4.219 |
| Social Capital | 4.499 | 4.454 | 4.378 | 4.298 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.580 | 3.809 | 6.823 | 2.559 | 4.327 | 27 | 26 | 27 | 27 | 27 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5229 - 5229" | |||||||||
| CAEN Financial Year |
5229
|
|||||||||
Comments - Lomaco Intermed S.r.l.